Health and Healthcare
1482 Articles
The number of COVID-19 cases continues to rise, which will only create more demand for coronavirus stocks. 24/7 Wall Street…
Pfizer and BioNTech have progressed in their COVID-19 vaccine effort, according to the FDA. Two of the companies’ four coronavirus…
As of the most recently reported period, short sellers still favored Exxon, Pfizer and Microsoft above all other Dow stocks.
24/7 Wall St. has identified five defensive stocks that must greatly improve before they are deemed expensive or fully valued…
Pfizer is among the current frontrunners for a COVID-19 vaccine, so why is its stock down 13% year to date?…
24/7 Wall Street has picked out a few of the best and brightest coronavirus stocks that could still see a…
Pfizer and BioNTech have been collaborating to produce a messenger RNA based vaccine for the past few months, and this…
As of the most recently reported period, short sellers favored Exxon, Pfizer and Microsoft above all other Dow stocks.
As of the most recently reported period, short sellers favored Exxon, Pfizer and Microsoft above all other Dow stocks. The…
BioNTech and Pfizer stocks each made a handy gain on Monday after the companies announced the beginning of human trials…
Merck and Pfizer reported their most recent quarterly results before the opening bell Tuesday. Although markets appear to be recovering,…
Pharmaceutical giants Merck and Pfizer are expected to report their most recent quarterly results before the opening bell Tuesday.
The April 15 short interest data have been compared with the previous figures, and short interest moves in these selected…
Our top personal finance-related articles today. Your wallet will thank you later.